Literature DB >> 12552573

Potential association between endogenous leptin and sympatho-vagal activities in young obese Japanese women.

Tamaki Matsumoto1, Aya Miyatsuji, Takashi Miyawaki, Yukio Yanagimoto, Toshio Moritani.   

Abstract

Leptin is an adipocyte-derived hormone that decreases food intake and increases energy expenditure through the activation of the sympathetic nervous system (SNS). Notwithstanding recent intensive research, the underlying physiological mechanism of leptin as well as the etiology of obesity in humans remains elusive. The present study attempted to investigate the potential association between endogenous circulating leptin and sympatho-vagal activities in age- and height-matched obese and nonobese healthy young women. Plasma leptin concentrations were measured by radioimmunoassay. The autonomic nervous system activity was assessed during the resting condition by means of a recently devised power spectral analysis of heart rate variability, which serves to identify three separate frequency components, very low (VLO), low (LO), and high (HI). Plasma leptin concentrations were greater in the obese than in the control group (45.7 +/- 5.89 vs. 11.2 +/- 1.10 ng. ml(-1), P < 0.01). As to the contribution of endogenous leptin to SNS activity, both the ratios of the VLO frequency component reflecting thermoregulatory sympathetic function and the global SNS index [(VLO + LO)/HI] to plasma leptin concentration were markedly reduced in the obese compared to the control group (VLO per leptin: 5.9 +/- 1.39 vs. 37.8 +/- 8.1 ms(2). ml. ng(-1), P < 0.01; SNS index per leptin: 0.04 +/- 0.008 vs. 0.33 +/- 0.01 ml c. ng(-1), P < 0.01). Additionally, a nonlinear regression analysis revealed that these ratios exponentially decreased as a function of body fat content (VLO per leptin r(2) = 0.57, P < 0.01; SNS index per leptin r(2) = 0.53, P < 0.01). Our data suggest that reduced sympathetic responsiveness to endogenous leptin production, implying peripheral leptin resistance, might be a pathophysiological feature of obesity in otherwise healthy young women. The findings regarding the association of leptin, body fat content, and SNS activity further indicate that the 30% of total body fat, which has been used as a criterion of obesity, might be a critical point at which leptin resistance is induced. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552573     DOI: 10.1002/ajhb.10111

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  6 in total

1.  Sympathetic Activity Assessed during Exercise Recovery in Young Obese Females.

Authors:  R Lee Franco; Stacey H Privett; Mary K Bowen; Edmund O Acevedo; James A Arrowood; Edmond P Wickham; Ronald K Evans
Journal:  J Pediatr       Date:  2015-05-23       Impact factor: 4.406

Review 2.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

3.  Leptin, adiponectin, and heart rate variability among police officers.

Authors:  Luenda E Charles; Cecil M Burchfiel; Khachatur Sarkisian; Shengqiao Li; Diane B Miller; Ja K Gu; Desta Fekedulegn; John M Violanti; Michael E Andrew
Journal:  Am J Hum Biol       Date:  2014-10-01       Impact factor: 1.937

4.  Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction.

Authors:  M Tolga Dogru; M Murad Basar
Journal:  Int Urol Nephrol       Date:  2009-10-29       Impact factor: 2.370

Review 5.  Leptin-A Potential Bridge between Fat Metabolism and the Brain's Vulnerability to Neuropsychiatric Disorders: A Systematic Review.

Authors:  Gilmara Gomes de Assis; Eugenia Murawska-Ciałowicz
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

Review 6.  Sex Differences in Adiposity and Cardiovascular Diseases.

Authors:  Haoyun Li; Daniels Konja; Luyao Wang; Yu Wang
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.